Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors

ArticleView

Images

(A) 2D visualized interaction of the redocked ligand with key residues of SARS-CoV-2 NSP16 (PDB ID: 8F4S). (B) Superimposition of the native ligand (grey) and the redocked ligand (cyan) showing similar binding conformations within the cryptic site, with an RMSD value of 1.411 Å indicating a reliable redocking result (DOCK6 docking result; visualized by the Biovia Discovery Studio).

Cite This Article

Vancouver Style ::